Latest filing published 02 Sept 2026 for BIOMERIEUX. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Pierre BOULUD on record concern Biomerieux, in the capacity of chief executive. The record holds 8 filings, for trades running from 26 February 2022 to 31 August 2026.
In open-market terms, that means 3 purchases on one side and 1 sale worth €673k on the other. The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants. In 2026 alone, the filings show 1 purchase and no sales.
The record was last updated on 2 September 2026 with an open-market purchase in Biomerieux. The median gap between a trade and its publication by AMF is 4 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations